Form 4: Dyne Therapeutics Director Sells Shares After Option Exercise

Dyne Therapeutics director Carlo Incerti exercised stock options and sold the resulting shares on November 18, 2024.

Summary

• Carlo Incerti, a director at Dyne Therapeutics, exercised stock options to acquire 16,500 shares of common stock at a price of $8.69 per share on November 18, 2024.
• Immediately following the exercise, Mr. Incerti sold the 16,500 shares on the same day at a weighted average price of $28.73 per share.
• The sale was executed in multiple transactions with prices ranging from $28.47 to $29.13 per share.
• After these transactions, Mr. Incerti no longer directly owns any common stock of Dyne Therapeutics.

Sentiment

Score: 5

Explanation: This is a neutral transaction, reflecting a director exercising options and selling shares, which is a common practice. There is no indication of positive or negative sentiment.

Industry Context

This is a standard Form 4 filing, which is a routine disclosure of insider transactions. It is common for directors and officers to exercise stock options and sell shares.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies, and this transaction is consistent with typical insider trading activity.
• The exercise of options and subsequent sale of shares is a common occurrence for company directors and officers.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine insider transaction.

Key Dates

Keywords

Dyne Therapeutics, stock options, insider trading, Form 4, share sale, director, equity